Navigation Links
VetStem Biopharma -Regenerative Cell Therapy has processed over 11,000 samples
Date:4/29/2015

Poway, CA (PRWEB) April 29, 2015

The leading Regenerative Veterinary Medicine Company, VetStem Biopharma., is proud to announce that its regenerative stem cell therapy has processed more than 11,000 samples. VetStem was founded in 2002, seeking to discover a successful treatment for horses with potentially fatal injuries to tendons and ligaments.

In 2003 VetStem signed a worldwide exclusive license for adipose-derived (fat derived) stem cell technology for veterinary application, and the first horse was treated in January 2004. Shortly after, the first dogs were treated with VetStem Regenerative Cell Therapy. VetStem started providing stem cell banking to their clients from the beginning so that cells could be stored for future use. By August of 2005 500 horses had been treated. VetStem had effectively introduced a new, natural, injectable treatment to the equine and small animal veterinary industry that could serve as an alternative to euthanasia for some conditions.

Although the large majority of animals treated have been horses, dogs and cats, VetStem has provided services for exotic species as well. The U.S. Navy, Office of Naval Research, awarded VetStem a contract to engage in a collaborative study of stem cell biology in marine mammals in 2009. From this, the first peer-reviewed article was published showing successful isolation of stem cells from dolphin fat. Several media outlets featured a story on a panther from the Tallahassee Museum who received stem cell therapy by VetStem for arthritis of the elbow in 2011. After the therapy he was able to stand up and scratch on his favorite tree with both front paws.

VetStem continues to strive to bring the best Regenerative Medicine therapies to the market to help provide better quality of life for animals. Dr. Robert Harman, CEO and Founder of VetStem has spoken at many human and veterinary conferences sharing the results of real treatments. He has also authored or co-authored numerous peer-reviewed papers on stem cells as well as written book chapters on stem cells.

“I started VetStem in order to help horses with career ending injuries to their tendons and ligaments but so many more animals have been saved from a life of pain or even from euthanasia. I feel privileged and excited to be a part of this therapy that has changed how veterinary medicine is practiced as well as contributing to changes in human medicine,” Robert Harman, DVM, CEO and Founder of VetStem

About VetStem Biopharma.
Since its formation in 2002, VetStem has endeavored to improve the lives of animals through regenerative medicine. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, VetStem pioneered the use of regenerative stem cells for horses, dogs, and cats. In 2004 the first horse was treated with VetStem Regenerative Cell Therapy. Ten years later VetStem celebrated its 10,000th animal treated. As animal advocates, veterinarians, veterinary technicians, and cell biologists, the team at VetStem tasks themselves with the responsibility of discovering, refining, and bringing to market innovative medical therapies that utilize the body’s own healing and regenerative cells.

Contact: Kristi Hauta
Marketing Operations Manager
VetStem Biopharma
12860 Danielson Court, Suite B
Poway, CA 92064
858-748-2004 ext 208
khauta@vet-stem.com

Read the full story at http://www.prweb.com/releases/2015/04/prweb12682830.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related biology technology :

1. Vet-Stem, Inc. Meets New Milestones and Changes Name to VetStem Biopharma
2. Alise Reicin Joins the Biopharmaceutical Business of Merck KGaA, Darmstadt, Germany as Head of Global Clinical Development
3. PAREXEL Strengthens Commitment To Global Biopharmaceutical Workforce With New PAREXEL Academy Programs
4. PlasmaTech Biopharmaceuticals Appoints Alpha-1 Expert Robert Sandhaus, MD, Ph.D. To Its Scientific Advisory Board
5. PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements
6. PlasmaTech Biopharmaceuticals Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea
7. Clinical Researchers and Pharmaceutical Regulatory Affairs Pros Benefit from BioPharma Institute's Newly Accredited Training Programs
8. Benitec Biopharma Doses Fourth Patient In Hepatitis C Trial
9. PDL BioPharma Announces Conversion Rate Adjustment for Convertible Note
10. PDL BioPharma Announces Dismissal of Third and Final Shareholder Lawsuit
11. Synageva BioPharma Reports 2014 Full Year Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2019)... ABABA, Ethiopia (PRWEB) , ... May 21, 2019 ... ... für Brauerei in Berlin (VLB) today officially opened the inaugural Africa Brewing Conference ... brewing and malting industry in Africa. The event, which is supported through a ...
(Date:5/14/2019)... TOWNSHIP, N.J. (PRWEB) , ... May 13, 2019 ... ... of custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device ... new Heliumleak.com company website. The redesigned website aims to improve LDA’s ability to ...
(Date:5/7/2019)... ... May 06, 2019 , ... "The new Liquid Nitrogen Best ... being asked to store cellular products being used in adoptive therapy research ... world leaders, who have shared their expertise in building and managing facilities to ...
(Date:5/2/2019)... ... April 30, 2019 , ... ... standard, REPROCELL USA Inc. has demonstrated its ability to provide various services ... aims to enhance customer satisfaction through the effective implementation of its quality ...
Breaking Biology Technology:
(Date:5/8/2019)... ... May 08, 2019 , ... FISO Technologies proudly presents ... and a lead-in fiber of 100 microns. With dimensions smaller than any competitive ... as the world leader in the development of fiber optic sensors & signal ...
(Date:5/2/2019)... ... April 30, 2019 , ... Global molecular diagnostics company ... Holotype HLA and other Omixon products will be featured in 12 poster presentations ... in Lisbon, Portugal. Among the major scientific events, Omixon’s Lunch Symposium ...
(Date:4/27/2019)... ... April 26, 2019 , ... Washington State University’s Center for ... than 30 student venture teams, representing nearly 150 students, presented their business ideas ... The top five teams in the College League were awarded prize money with ...
Breaking Biology News(10 mins):